Trials / Withdrawn
WithdrawnNCT00187304
ACTION - Anticoagulation Treatment Influence on Post-operative Patients
Anticoagulation Treatment Influence on Post-operative Patients -Action SJM EPIC Trial
- Status
- Withdrawn
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Abbott Medical Devices · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to compare two different regimens of therapy, AVK and ASA (aspirin), in the early postoperative period after aortic valve replacement with SJM Epic™ or SJM Epic™ Supra Porcine Bioprosthetic Heart Valve by establishing the adverse event free survival rate at 3 month post intervention follow-up of the 2 groups(with special focus on thromboembolic events and bleedings).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Aortic valve replacement |
Timeline
- Start date
- 2005-09-01
- First posted
- 2005-09-16
- Last updated
- 2019-02-04
Source: ClinicalTrials.gov record NCT00187304. Inclusion in this directory is not an endorsement.